Brief: ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital

ProQR Therapeutics NV

30/12/2021 12:59

Dec 30 (Reuters) - ProQR Therapeutics NV  PRQR.O :
    * PROQR ANNOUNCES AMENDMENT TO CONVERTIBLE DEBT FINANCING
AGREEMENT WITH PONTIFAX VENTURES AND KREOS CAPITAL
    * PROQR THERAPEUTICS NV - AMENDMENT PROVIDES CO WITH ACCESS
TO UP
TO ADDITIONAL $90 MILLION IN CONVERTIBLE DEBT FINANCING IN 3 NEW
TRANCHES OF $30 MILLION EACH
    * PROQR THERAPEUTICS NV -  CONVERTIBLE DEBT FINANCING WILL
MATURE
OVER A 54 MONTH PERIOD AND HAVE AN INTEREST-ONLY PERIOD OF 33
MONTHS
    * PROQR THERAPEUTICS NV - THREE NEW TRANCHES REPLACE TWO
UNDRAWN
TRANCHES UNDER ORIGINAL CONVERTIBLE DEBT FINANCING AGREEMENT

Source text for Eikon:  ID:nGNX7dx6pJ 
Further company coverage:  PRQR.O 

 ((Reuters.Briefs@thomsonreuters.com;;))